For the twelve months ended Jul 4, 2026, Silicon Laboratories Inc. reported $855.89M of revenue and -$39.11M of net income.
SLAB revenueQ2 2026$228.19M
- Quarter YoY
- +18.3%
- QoQ
- +6.9%
- FY YoY
- +34.3%
- 5Y CAGR
- +9.0%
- 10Y CAGR
- +2.0%
SLAB revenue was $228.19M in fiscal Q2 2026 (ended Jul 4, 2026), up 18.3% from a year earlier and up 6.9% from the prior quarter. For the full fiscal 2025 it was $784.76M, up 34.3% from fiscal 2024. Compound annual growth was +9.0% over 5 years and +2.0% over 10 years. It rose in 7 of the last 10 fiscal years.
SLAB net incomeQ2 2026-$10.59M
SLAB net income was -$10.59M in fiscal Q2 2026 (ended Jul 4, 2026), compared with -$21.82M a year earlier. For the full fiscal 2025 it was -$64.91M, compared with -$191.01M in fiscal 2024.
SLAB EPSQ2 2026-$0.32
SLAB diluted EPS was -$0.32 in fiscal Q2 2026 (ended Jul 4, 2026), compared with -$0.67 a year earlier. For the full fiscal 2025 it was -$1.98, compared with -$5.93 in fiscal 2024.
SLAB free cash flowQ2 2026-$26.83M
- 10Y CAGR
- -3.5%
SLAB free cash flow was -$26.83M in fiscal Q2 2026 (ended Jul 4, 2026), compared with -$3.79M a year earlier. For the full fiscal 2025 it was $65.79M, compared with -$25.66M in fiscal 2024. Compound annual growth was -3.5% over 10 years.
Source: XBRL data Silicon Laboratories Inc. files with the SEC, latest filing dated Aug 11, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.